Health CanadaGeneral Alert
OPTIMARK (gadoversetamide injection) – Association with Nephrogenic Systemic Fib...
Published: January 12, 2010Recall ID: 24310Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
OPTIMARK (gadoversetamide injection) – Association with Nephrogenic Systemic Fibrosis (NSF) in Patients with Renal Impairment – For the Public
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24310 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/optimark-gadoversetamide-injection-association-nephrogenic-systemic-fibrosis-nsf |
| Issue | Product safety |
| Title | OPTIMARK (gadoversetamide injection) – Association with Nephrogenic Systemic Fibrosis (NSF) in Patients with Renal Impairment – For the Public |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2010-01-12 |
| Organization | Marketed health products |